Skip to content

Mongolian Warm Needling Acupuncture in the Treatment of Secondary Sciatica

Mongolian Warm Needling Acupuncture in the Treatment of Secondary Sciatica

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17012175
Enrollment
Unknown
Registered
2017-07-29
Start date
2017-07-12
Completion date
Unknown
Last updated
2019-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sciatica

Interventions

Mongolian warm acupuncture group:Warm acupuncture
Drug group:Ibuprofen sustained release tablets

Sponsors

Inner Mongolia Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Between 20-75 years of age (excluding other causes of old age disease), the course of disease in 1 month - 2 years; 2. According to plan to adhere to the treatment, and with the subject of research, willing to sign informed consent; 3. No treatment for analgesia within one month prior to treatment. Neuropathic interventional clinical trials to verify their effectiveness and safety.

Exclusion criteria

Exclusion criteria: 1. Those who do not meet the inclusion criteria; 2. Non-co-operatives, including those who can not adhere to treatment or use other treatment, affect the data collection and evaluation of the efficacy of; 3. Pregnant women, critically ill or disease patients; 4. Other do not meet the Inner Mongolia Medical University Medical Ethics Committee on the relevant provisions of medical clinical trials.

Design outcomes

Primary

MeasureTime frame
Barthel life function evaluation;Evaluation of low back pain in JOA;VAPS visual analogue pain score;

Countries

China

Contacts

Public ContactBO AGULA

Inner Mongolia Medical University

agula_b@163.com+86 15964539710

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026